These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35613045)

  • 21. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.
    Barresi V; Reggiani Bonetti L; Branca G; Di Gregorio C; Ponz de Leon M; Tuccari G
    Virchows Arch; 2012 Dec; 461(6):621-8. PubMed ID: 23093109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.
    Barresi V; Branca G; Ieni A; Reggiani Bonetti L; Baron L; Mondello S; Tuccari G
    Virchows Arch; 2014 Jun; 464(6):655-62. PubMed ID: 24771119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
    Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
    World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer.
    Huh JW; Lee WY; Shin JK; Park YA; Cho YB; Kim HC; Yun SH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):471-477. PubMed ID: 30603899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters.
    Pai RK; Hartman D; Schaeffer DF; Rosty C; Shivji S; Kirsch R; Pai RK
    Histopathology; 2021 Sep; 79(3):391-405. PubMed ID: 33590485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poorly Differentiated Clusters: Clinical Impact in Colorectal Cancer.
    Barresi V; Reggiani Bonetti L; Ieni A; Caruso RA; Tuccari G
    Clin Colorectal Cancer; 2017 Mar; 16(1):9-15. PubMed ID: 27444718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranous S100A10 involvement in the tumor budding of colorectal cancer during oncogenesis: report of two cases with immunohistochemical analysis.
    Arai K; Ishimatsu H; Iwasaki T; Tsuchiya C; Sonoda A; Ohata K
    World J Surg Oncol; 2020 Nov; 18(1):289. PubMed ID: 33160379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma.
    Yonemura K; Kajiwara Y; Ao T; Mochizuki S; Shinto E; Okamoto K; Hase K; Ueno H
    Am J Surg Pathol; 2019 Oct; 43(10):1341-1348. PubMed ID: 31318710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
    González IA; Bauer PS; Liu J; Chatterjee D
    Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.
    Jun SY; Chung JY; Yoon N; Jung ES; Oh YH; Hong SM
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer.
    Mitrovic B; Handley K; Assarzadegan N; Chang HL; Dawson HAE; Grin A; Hutchins GGA; Magill L; Quirke P; Riddell RH; Gray RG; Kirsch R;
    Clin Colorectal Cancer; 2021 Sep; 20(3):256-264. PubMed ID: 34099382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Budding Assessment in Colorectal Carcinoma: Normalization Revisited.
    Cyr DP; Pun C; Shivji S; Mitrovic B; Duan K; Tomin R; Sari A; Brar A; Zerhouni S; Brar MS; Kennedy ED; Swallow CJ; Kirsch R; Conner JR
    Am J Surg Pathol; 2024 Mar; 48(3):251-265. PubMed ID: 38108373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.
    Lionti S; Reggiani Bonetti L; Bettelli S; Spallanzani A; Gelsomino F; Barresi V
    Hum Pathol; 2018 Aug; 78():115-124. PubMed ID: 29715463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.